Refrigerators / freezers
In the fast-paced sectors of pharmaceutical R&D, diagnostics, and biotechnology, the precision of your equipment often dictates the success of your pipeline. For many laboratories across the UK and Ireland, the SP VirTis range of freeze dryers has long been the gold standard for reliable lyophilisation. However, even the most robust systems eventually face the challenges of time. If your pilot or R&D freeze dryer is beginning to show its age, it may be doing more than just slowing down your workflow, it could be putting your research quality at risk.
Maintaining legacy equipment often feels like a safe, cost-effective choice, at least up to a point, but "making do" can lead to unforeseen complications. Mechanical components naturally exhibit wear and tear after years of intensive operation even with the best maintenance protocols in place, which can manifest as sudden, expensive repairs and/or critical production downtime.
Perhaps more pressing is the issue of software and control system obsolescence. Older interfaces often lack the sophisticated data monitoring and user-friendly controls required for modern, high-efficiency lab and R&D operations. This creates a level of uncertainty that today's lab managers and R&D directors simply cannot afford when handling high-value samples.
As the exclusive distributor for SP VirTis freeze dryers in the UK and Ireland, Biopharma Group offers a streamlined pathway to modernise your facility through a dedicated upgrade and trade-in programme. This initiative allows organisations to swap their existing SP (an ATS Company), R&D or pilot systems for the latest cutting-edge models, such as the Genesis 30, Ultra Prime, Ultra Prime 30, or LyoStar 4.0.
Upgrading is not merely a replacement of hardware; it is an investment in operational peace of mind. Newer systems provide:
Whether your goal is to upscale your batch size or simply replace a unit that is nearing the end of its guaranteed support life, the transition is designed to be as efficient as possible. By trading in aging units, laboratories can offset the cost of new technology while ensuring their infrastructure stays ahead of the curve.
For professionals in the UK and Ireland looking to safeguard their research and enhance production efficiency, now is the time to evaluate the health of your lyophilisation suite.
Contact the product specialists at Biopharma Group to discuss your requirements. Use reference VIRTIS-BPS-UPGRADE to discover how a new or larger SP VirTis system can transform your laboratory's capabilities.
ILM Guide 2026/27
Product directory
